ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BIENVENIDO AQUINO

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,285Medicare Part D Prescriptions Filled, Including Refills

Rank: 242 out of 3647

$531K Total Retail Price of All Prescriptions

Rank: 1007 out of 3647

597 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 18,880 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,069 1,039 1 1
OMEPRAZOLE 890 860 2 3
ALPRAZOLAM 627 610 3 31
LISINOPRIL 604 604 4 4
TEMAZEPAM 588 563 5 47
LEVOTHYROXINE SODIUM 583 564 6 5
ATORVASTATIN CALCIUM 573 557 7 13
ENALAPRIL MALEATE 538 513 8 35
ALENDRONATE SODIUM 476 475 9 23
ATENOLOL 456 430 10 10
METOPROLOL TARTRATE 429 420 11 7
FAMOTIDINE 427 415 12 61
METFORMIN HCL 355 329 13 6
RANITIDINE HCL 334 321 14 29
VIAGRA 320 313 15 69
LORAZEPAM 319 311 16 73
HYDROCHLOROTHIAZIDE 312 312 17 9
WARFARIN SODIUM 310 307 18 15
CLOPIDOGREL 287 285 19 26
FUROSEMIDE 279 279 20 8
GLIMEPIRIDE 257 257 21 45
LOSARTAN POTASSIUM 244 244 22 11
AMLODIPINE BESYLATE 229 226 23 2
CARVEDILOL 224 224 24 20
FLUOXETINE HCL 215 215 25 68
PLAVIX 212 212 26 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 198 192 27 36
ZOLPIDEM TARTRATE 193 191 28 14
DIGOXIN 191 191 29 51
BENAZEPRIL HCL 184 184 30 71
FELODIPINE ER 180 180 31 186
METOPROLOL SUCCINATE 168 168 32 18
LOSARTAN-HYDROCHLOROTHIAZIDE 165 165 33 48
GLIPIZIDE 164 164 34 41
GLYBURIDE-METFORMIN HCL 149 149 R 35 94
DIOVAN 149 136 35 40
TAMSULOSIN HCL 146 142 37 28
FINASTERIDE 141 141 38 66
VERAPAMIL ER 136 136 39 99
ESCITALOPRAM OXALATE 132 121 40 65
NIFEDIPINE ER 128 128 41 67
GABAPENTIN 126 123 42 17
IBUPROFEN 126 115 42 55
PAROXETINE HCL 120 120 44 60
DONEPEZIL HCL 118 118 45 30
CRESTOR 117 107 46 19
ISOSORBIDE MONONITRATE ER 116 116 47 56
POTASSIUM CHLORIDE 114 114 48 24
ALLOPURINOL 108 108 49 37
DOXAZOSIN MESYLATE 107 107 50 57
TERAZOSIN HCL 104 104 51 103
LOVAZA 101 101 52 117
TRIAMTERENE-HCTZ 101 92 52 58
FLUTICASONE PROPIONATE 96 96 54 32
JANUMET 90 90 55 202
CLONIDINE HCL 89 89 56 46
VENTOLIN HFA 88 82 57 88
AMLODIPINE BESYLATE-BENAZEPRIL 88 88 57 74
NAMENDA 87 87 59 49
ADVAIR DISKUS 86 84 60 52
INDAPAMIDE 86 86 60 296
NAPROXEN 85 78 62 70
DILTIAZEM ER 81 81 63 167
LOVASTATIN 76 76 64 21
EASY TOUCH 73 73 65 279
PRAVASTATIN SODIUM 65 57 66 16
CITALOPRAM HBR 64 64 67 25
GLYBURIDE 60 60 R 68 54
BENICAR HCT 59 59 69 165
LACTULOSE 56 56 70 128
PENTOXIFYLLINE 55 55 71 180
JANUVIA 53 53 72 72
NEXIUM 51 51 73 44
CLOTRIMAZOLE-BETAMETHASONE 50 50 74 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.